Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Fate Therapeutics Q1 Earnings

Fate Therapeutics (NASDAQ:FATE) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
May 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Fate Therapeutics (NASDAQ:FATE) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Fate Therapeutics beat estimated earnings by 10.53%, reporting an EPS of $-0.68 versus an estimate of $-0.76.

Revenue was up $7.27 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.05 which was followed by a 0.38% drop in the share price the next day.

To track all earnings releases for Fate Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

UMB Financial: Q3 Earnings Insights

By Benzinga Insights
Today, 3:26 AM
UMB Financial (NASDAQ:UMBF) reported its Q3 earnings results on Tuesday, October 26, 2021 at 05:00 PM. Here's what investors need to know about the announcement. Earnings UMB Financial beat their estimated earnings by 8.33%, which did not surprise analysts.

UMBF